BIOMED INVEST

BioMed Invest

#Financial #More

BIOMED INVEST

Status:
Active


Investments List

Date Company Article Money raised
2019-09-12 Inotrem BioMed Invest investment in Series B - Inotrem 39 M EUR

More informations about "BioMed Invest"

biomedvc.com | Portfolio

BioMedInvest AG I in liquidation was a healthcare-dedicated investment company, providing private equity financing to early- to mid-stage companies in the biotechnology, emerging โ€ฆSee details»

BioMedPartners closes new venture capital fund

Jun 3, 2018 Main investors in the BioMedInvest III healthcare venture capital fund are the European Investment Fund and the Berner Kantonalbank ().According to Markus Hosang, โ€ฆSee details»

BioMedInvest II: Fund Performance - PitchBook

BioMedInvest II General Information Description. BioMedInvest II is a venture capital fund managed by BioMedPartners. The fund is located in Basel, Switzerland and invested in โ€ฆSee details»

BioMed Ventures - Investments, Portfolio & Company Exits

BioMed Ventures 's most notable exits include Compass Therapeutics, Inc., Sensely, and Syndax Pharmaceuticals. Which industries has this organization had the most exits in? ShowSee details»

BioMedInvest has new CHF 95M investment fund - Science|Business

Jan 21, 2009 With this closing, BioMedPartners, founded in 2003, has raised a total of over CHF 240 million (โ‚ฌ169.6 million). The new fund, BioMedInvest II, will be dedicated to investing in โ€ฆSee details»

BioMed Ventures - Golden

Founded in 2010, BioMed Ventures is a San Diego, California based venture capital firm. They are the investment arm of BioMed Realty. They are the investment arm of BioMed Realty. โ€ฆSee details»

BioMedInvest III: Fund Performance - PitchBook

European Investment Fund: Fund of Funds: Current: 01-Feb-2018: Original: To view BioMedInvest IIIโ€™s complete limited partners history, request access » BioMedInvest III โ€ฆSee details»

BioMedPartners schliessen Wagniskapitalfonds - Basel Area โ€ฆ

Mar 6, 2018 Das Basler Wagniskapitalunternehmen BioMedPartners hat den Fonds BioMedInvest III mit einem Kapital von 100 Millionen Franken geschlossen. Durch โ€ฆSee details»

Shanghai Biomedical Industrial Equity Investment Fund

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry. New. ... Shanghai Biomedical Industrial Equity Investment โ€ฆSee details»

Biomedical Innovation II fund closure | Wellington UK Professional

BOSTON, 13 APRIL 2023 โ€” Wellington Management (โ€œWellingtonโ€ or the โ€œFirmโ€), one of the worldโ€™s largest independent investment management firms, today announced the close of โ€ฆSee details»

Fluid Biomed Closes $27 Million USD Series A to Fund Expanded โ€ฆ

Jan 7, 2025 Calgary-based medical device start-up Fluid Biomed has secured $27 million USD in Series A funding to fuel the development of its innovative stent for brain aneurysms. Fluid โ€ฆSee details»

BioMedPartners closes new venture capital fund - BaseLaunch

Mar 6, 2018 The Basel-based company will invest 100 million Swiss francs in 12 to 15 biopharmaceutical, medical device and diagnostics companies. It will also take an active role โ€ฆSee details»

Micron Biomedical - Funding, Financials, Valuation & Investors

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market. New. ... How much funding has this organization raised over time? โ€ฆSee details»

BioMedInvest I: Fund Performance - PitchBook

BioMedInvest I General Information Description. BioMedInvest I is a venture capital fund managed by BioMedPartners. The fund is located in Basel, Switzerland, and invested in โ€ฆSee details»

Programme Invest In Biomed - Eurobiomed

The Invest In Biomed program is made for you! Le programme Invest In Biomed. 6 workshops collective or individual March to June 2025, led by experts in health and fundraising. Mars โ€ฆSee details»

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services ...

6 days ago Humaneticsโ€™ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out โ€ฆSee details»

Patricia Industries' subsidiary Advanced Instruments to acquire and ...

4 days ago Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova โ€ฆSee details»

Principles for the Future of Biomedical Research in the United โ€ฆ

Feb 19, 2025 The US National Institutes of Health (NIH) is the largest public funder of biomedical and behavioral research in the world, investing most of its nearly $48 billion annual โ€ฆSee details»

Programme Invest In Biomed - Eurobiomed

Le programme Invest In Biomed. 6 ateliers collectifs ou individuels de mars à juin 2025, animés par des experts en santé et levée de fonds. Mars 2025. Mars 2025. Revue flash de votre โ€ฆSee details»

A Turn Around for Origin BioMed | Government of Nova Scotia โ€ฆ

Dec 2, 2013 Origin BioMed's performance has increased customer demand for its product and now new marketing and distribution is needed in its larger markets. Nova Scotia Business Inc. โ€ฆSee details»